Literature DB >> 3668610

Studies on estrogen induced pituitary tumor in the rat with special reference to the relationship of the tuberoinfundibular dopamine neuron system.

M Fujimoto1, E Yoshino, K Hirakawa, K Chihara, Y Ibata.   

Abstract

Pituitary tumors were experimentally induced in female Wistar rats by repeated injections of estradiol dipropionate. The hypothalamus and pituitary tumors were studied simultaneously by fluorescence histochemistry and immunohistochemistry. The pituitary gland became larger with a concomitant increase of serum prolactin in proportion to the dose of estrogen. Estrogen-induced pituitary tumor exhibited a proliferating prolactin cells by the peroxidase immunohistochemical method. Ultramicroscopical findings showed that these tumor cells were in an extremely hyperfunctional state. The dopamine neuronal perikarya in the hypothalamic arcuate nucleus and their terminals in the external layer of the median eminence were examined by fluorescence histochemistry in the rats bearing estrogen induced pituitary tumor and it was concluded that in our experimental conditions, estrogen effected directly on pituitary rather than on the hypothalamus and consequently dopamine synthesis in the arcuate neurons and its release into portal capillaries were accelerated simultaneously in order to inhibit prolactin secretion from tumor cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3668610     DOI: 10.1007/bf02571303

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  18 in total

1.  DEPLETION OF PROLACTIN-INHIBITING ACTIVITY OF RAT HYPOTHALAMUS BY ESTRADIOL OR SUCKLING STIMULUS.

Authors:  A RATNER; J MEITES
Journal:  Endocrinology       Date:  1964-09       Impact factor: 4.736

Review 2.  Multiple receptors for dopamine.

Authors:  J W Kebabian; D B Calne
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

3.  Estrogen-sensitive cells. Hormone receptors in tumors and cells in culture.

Authors:  J Mester; R Brunelle; I Jung; C Sonnenschein
Journal:  Exp Cell Res       Date:  1973-10       Impact factor: 3.905

4.  Estrogen receptor in a prolactin secreting pituitary tumor (MtTW5).

Authors:  W L McGuire; M DeLaGarza; G C Chamness
Journal:  Endocrinology       Date:  1973-10       Impact factor: 4.736

5.  Studies on the mechanism of the dopamine-mediated inhibition of prolactin secretion.

Authors:  R M MacLeod; J E Lehmeyer
Journal:  Endocrinology       Date:  1974-04       Impact factor: 4.736

6.  An immunohistochemical study of estrogen-induced pituitary adenoma in rat.

Authors:  G Ueda; J Otsuka; T Mori; K Nagai
Journal:  Wakayama Med Rep       Date:  1968-12

7.  Tumorous development of in situ and grafted anterior pituitaries in female rats treated with diethylstilbesterol.

Authors:  C W Welsch; T Jenkins; Y Amenomori; J Meites
Journal:  Experientia       Date:  1971

8.  Pituitary hormones and prolactin-releasing activity in rats with primary estrogen-induced pituitary tumors.

Authors:  K Nakagawa; T Obara; K Tashiro
Journal:  Endocrinology       Date:  1980-03       Impact factor: 4.736

9.  Damage to hypothalamic dopaminergic neurons is associated with development of prolactin-secreting pituitary tumors.

Authors:  D K Sarkar; P E Gottschall; J Meites
Journal:  Science       Date:  1982-11-12       Impact factor: 47.728

10.  Cytopathological effects of estradiol on the arcuate nucleus of the female rat. A possible mechanism for pituitary tumorigenesis.

Authors:  J R Brawer; C Sonnenschein
Journal:  Am J Anat       Date:  1975-09
View more
  5 in total

1.  Comparison of NTP historical control tumor incidence rates in female Harlan Sprague Dawley and Fischer 344/N Rats.

Authors:  Gregg E Dinse; Shyamal D Peddada; Shawn F Harris; Susan A Elmore
Journal:  Toxicol Pathol       Date:  2010-07-09       Impact factor: 1.902

2.  Vasoactive intestinal peptide in the human pituitary gland and adenomas. An immunocytochemical study.

Authors:  D W Hsu; P N Riskind; E T Hedley-Whyte
Journal:  Am J Pathol       Date:  1989-08       Impact factor: 4.307

Review 3.  Estrogen action in the regulation of cell proliferation, cell survival, and tumorigenesis in the rat anterior pituitary gland.

Authors:  T J Spady; R D McComb; J D Shull
Journal:  Endocrine       Date:  1999-12       Impact factor: 3.633

4.  The immunophilin-like protein XAP2 is a negative regulator of estrogen signaling through interaction with estrogen receptor α.

Authors:  Wen Cai; Tatiana V Kramarova; Petra Berg; Marta Korbonits; Ingemar Pongratz
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

5.  Structure of the TPR domain of AIP: lack of client protein interaction with the C-terminal α-7 helix of the TPR domain of AIP is sufficient for pituitary adenoma predisposition.

Authors:  Rhodri M L Morgan; Laura C Hernández-Ramírez; Giampaolo Trivellin; Lihong Zhou; S Mark Roe; Márta Korbonits; Chrisostomos Prodromou
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.